Sara van den Berg

75 3 CMV on influenza vaccination: a systematic review 42. Alonso Arias, R., et al., Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system. J Virol, 2013. 87(8): p. 4486-95. 43. Kim, D.-K. and B. Poudel, Tools to Detect Influenza Virus. Yonsei Med J, 2013. 54(3): p. 560-566. 44. Pyhala, R., et al., Early kinetics of antibody response to inactivated influenza vaccine. Clin Diagn Virol, 1994. 1(5-6): p. 271-8. 45. He, X.S., et al., Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol, 2006. 80(23): p. 11756-66. 46. Beyer, W.E., et al., Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res, 2004. 103(1-2): p. 125-32. 47. Turner, J.E., et al., Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults. Age (Dordr), 2014. 36(1): p. 287-97. 48. den Elzen, W.P., et al., Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine, 2011. 29(29-30): p. 4869-74. 49. Haq, K., et al., Cytomegalovirus Seropositivity Predicts a Decline in the T-cell But Not the Antibody Response to Influenza in Vaccinated Older Adults Independent of Type 2 Diabetes Status. J Gerontol A Biol Sci Med Sci, 2016. 50. McElhaney, J.E., et al., Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes. BMJ Open Diabetes Res Care, 2015. 3(1): p. e000140. 51. Strindhall, J., et al., Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio. Infect Dis (Lond), 2016. 48(6): p. 436-42. 52. Den Elzen, W.P.J., et al., Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine, 2011. 29(29-30): p. 4869-4874. 53. Derhovanessian, E., et al., Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine, 2013. 31(4): p. 685-90. 54. Guidi, L., et al., Cytomegalovirus infection and response to influenza vaccination in inflammatory bowel disease patients on anti-TNF therapy. Journal of Crohn’s and Colitis, 2014. 8: p. S285. 55. Moro-García, M.A., et al., Relationship between functional ability in older people, immune system status, and intensity of response to CMV. Age, 2012. 34(2): p. 479-495. 56. Reed, R.G., R.N. Greenberg, and S.C. Segerstrom, Cytomegalovirus serostatus, inflammation, and antibody response to influenza vaccination in older adults: The moderating effect of beta blockade. Brain, Behavior, and Immunity, 2016. 57. Mukaka, M.M., Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J, 2012. 24(3): p. 69-71. 58. Looney, R.J., et al., Role of cytomegalovirus in the T-cell changes seen in elderly individuals. Clin Immunol, 1999. 90(2): p. 213-9. 59. Pawelec, G. and E. Derhovanessian, Role of CMV in immune senescence. Virus Res, 2011. 157(2): p. 175-9. 60. McElhaney, J.E., et al., The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine, 2012. 30(12): p. 2060-7. 61. Almanzar, G., et al., Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol, 2005. 79(6): p. 3675-83.